Limei Zhao
Suzhou, 215123, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Pharmacological inhibition of neddylation by MLN4924 protects against Coxsackievirus B3-induced myocarditis.
Journal: Biochemical pharmacology
Published: May 13, 2026
TMEM175 deficiency impairs autophagic degradation and alleviates mitochondrial oxidative damage in cardiomyocytes through AMPK activation.
Journal: Journal of molecular and cellular cardiology
Published: May 12, 2026
NADPH oxidase-dependent reactive oxygen species upregulate KCa3.1 to promote atrial fibroblast activation.
Journal: Experimental cell research
Published: March 12, 2026
Small-molecule LF3 alleviates angiotensin II-induced cardiac dysfunction via attenuating cardiac fibrosis.
Journal: Naunyn-Schmiedeberg's archives of pharmacology
Published: January 05, 2026
Oridonin exhibits potent anti-Coxsackievirus B3 activity and protects against viral myocarditis.
Journal: Biochemical and biophysical research communications
Published: September 08, 2025
KCa3.1 upregulation mediated by Ang II-induced JNK/AP-1 activation contributes to atrial fibrosis.
Journal: Cellular signalling
Published: November 29, 2024
Elevated KCa3.1 expression by angiotensin II via the ERK/NF-κB pathway contributes to atrial fibrosis.
Journal: Journal of molecular and cellular cardiology
Published: August 11, 2024
Showing 1-8 of 8
Last Updated: 09/26/2026